EP0387222A1 — Device in connection with an inhaler
Assigned to Draco AB · Expires 1990-09-12 · 36y expired
What this patent protects
The present invention refers to a device in connection with an inhaler intended for measuring and recording the course of inhalation of a patient. The device is intended for use in medication, e.g. in clinical tests, where there is a need of afterwards being able to control if…
USPTO Abstract
The present invention refers to a device in connection with an inhaler intended for measuring and recording the course of inhalation of a patient. The device is intended for use in medication, e.g. in clinical tests, where there is a need of afterwards being able to control if the patient has taken medicine in a prescribed way. The device comprises an electronical unit provided in the inhaler for recording of the time for each dosage of the medicine of the inhaler. A detector (16, 32, 36) is provided in the inhaler in connection with a passage for the airflow of the inhalation, whereby the detector detects the airflow of the inhalation through the inhaler as well as the availability of the medicine at the inhalation, so that a combination of these two detected values decides if and how the performed inhalation should be recorded in the electronical unit (11, 33, 35).
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.